Patent 7557187 was granted and assigned to Sanofi on July, 2009 by the United States Patent and Trademark Office.
The invention relates to new nucleic acid sequences of the family of tumour-suppressing genes related to the gene for the p53 protein, and to the corresponding protein sequences.